应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ENTA Enanta Pharmaceuticals Inc.
盘前交易 04-25 05:13:22 EDT
12.92
-0.23
-1.75%
最高
13.21
最低
12.63
成交量
9.03万
今开
13.02
昨收
13.15
日振幅
4.41%
总市值
2.73亿
流通市值
1.72亿
总股本
2,116万
成交额
116.69万
换手率
0.68%
流通股本
1,334万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Enanta Pharmaceuticals, Inc.盘中异动 大幅下跌5.14%
自选股智能写手 · 04-17
Enanta Pharmaceuticals, Inc.盘中异动 大幅下跌5.14%
Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速跳水5.02%报15.34美元
自选股智能写手 · 04-17
Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速跳水5.02%报15.34美元
Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.21%
自选股智能写手 · 04-04
Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.21%
Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.23%报16.13美元
自选股智能写手 · 04-03
Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.23%报16.13美元
Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.14%报16.77美元
自选股智能写手 · 03-28
Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.14%报16.77美元
Enanta Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.16%
自选股智能写手 · 03-26
Enanta Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.16%
Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.00%
自选股智能写手 · 03-26
Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.00%
Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报13.50美元
自选股智能写手 · 03-19
Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报13.50美元
Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.24%报14.83美元
自选股智能写手 · 03-06
Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.24%报14.83美元
Enanta Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%
自选股智能写手 · 03-01
Enanta Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%
Enanta Pharmaceuticals Inc盘中异动 急速拉升5.13%报14.15美元
自选股智能写手 · 02-27
Enanta Pharmaceuticals Inc盘中异动 急速拉升5.13%报14.15美元
Enanta Pharmaceuticals Inc盘中异动 下午盘股价大跌5.01%
自选股智能写手 · 02-23
Enanta Pharmaceuticals Inc盘中异动 下午盘股价大跌5.01%
Enanta Pharmaceuticals Inc盘中异动 早盘急速上涨5.12%
自选股智能写手 · 02-15
Enanta Pharmaceuticals Inc盘中异动 早盘急速上涨5.12%
Enanta Pharmaceuticals Inc盘中异动 早盘快速下跌8.69%
自选股智能写手 · 02-08
Enanta Pharmaceuticals Inc盘中异动 早盘快速下跌8.69%
美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司
Reuters · 02-08
美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司
Enanta Pharmaceuticals Inc盘中异动 股价大涨5.01%报12.99美元
自选股智能写手 · 02-07
Enanta Pharmaceuticals Inc盘中异动 股价大涨5.01%报12.99美元
Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻
Reuters · 02-06
Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻
Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻
Reuters · 02-02
Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻
Enanta Pharmaceuticals Inc盘中异动 下午盘股价大涨5.19%
自选股智能写手 · 02-02
Enanta Pharmaceuticals Inc盘中异动 下午盘股价大涨5.19%
Enanta Pharmaceuticals Inc盘中异动 快速上涨5.00%
自选股智能写手 · 01-24
Enanta Pharmaceuticals Inc盘中异动 快速上涨5.00%
加载更多
公司概况
公司名称:
Enanta Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司,利用稳健、化学驱动的方法和药物发现能力,成为小分子药物发现和开发的领导者,重点是病毒感染的治疗。该公司发现了gleCAPrevir,这是通过与艾伯维合作发现和开发的两种蛋白酶抑制剂中的第二种,用于治疗丙型肝炎病毒(HCV)的慢性感染。
发行价格:
--
{"stockData":{"symbol":"ENTA","market":"US","secType":"STK","nameCN":"Enanta Pharmaceuticals Inc.","latestPrice":12.92,"timestamp":1713988800000,"preClose":13.15,"halted":0,"volume":90291,"delay":0,"floatShares":13339993,"shares":21155983,"eps":-6.571136,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.23,"latestTime":"04-25 05:13:22 EDT","open":13.02,"high":13.21,"low":12.63,"amount":1166932.802412,"amplitude":0.044106,"askPrice":20.67,"askSize":200,"bidPrice":10.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.571136,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714051800000},"adr":0,"listingDate":1363838400000,"adjPreClose":12.92,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.92,"preClose":12.92,"latestTime":"16:12 EDT","volume":5587,"amount":72184.04,"timestamp":1713989565897},"volumeRatio":0.6843088928097205},"requestUrl":"/m/hq/s/ENTA?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2428347596","title":"Enanta Pharmaceuticals, Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428347596","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428347596?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:59","pubTimestamp":1713365947,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时59分,Enanta Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.14%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃,换手率分别为136.14%、37.41%、36.70%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.,振幅分别为80.94%、48.51%、41.02%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172259077a537fc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172259077a537fc9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428665807","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速跳水5.02%报15.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428665807","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428665807?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:59","pubTimestamp":1713297586,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时59分,Enanta Pharmaceuticals, Inc.股票出现异动,股价急速下挫5.02%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.67%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703594787e8107e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703594787e8107e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424339070","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424339070","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424339070?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:08","pubTimestamp":1712239708,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时08分,Enanta Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.21%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404220828791ecd9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404220828791ecd9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424802235","title":"Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.23%报16.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424802235","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424802235?lang=zh_cn&edition=full","pubTime":"2024-04-03 01:04","pubTimestamp":1712077479,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日01时04分,Enanta Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.23%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.60%。其相关个股中,Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Processa Pharmaceuticals, Inc.涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为883.04%、71.02%、59.66%,振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Gamida Cell Ltd.、Aditxt, Inc.,振幅分别为104.31%、61.39%、58.18%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403010440791e821a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403010440791e821a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422941299","title":"Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.14%报16.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422941299","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422941299?lang=zh_cn&edition=full","pubTime":"2024-03-28 02:08","pubTimestamp":1711562916,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日02时08分,Enanta Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.14%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。其相关个股中,Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为4081.86%、1285.45%、84.81%,振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.,振幅分别为123.48%、78.00%、59.87%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328020837861e1bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328020837861e1bc3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422106406","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422106406","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422106406?lang=zh_cn&edition=full","pubTime":"2024-03-26 23:12","pubTimestamp":1711465975,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日23时12分,Enanta Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.16%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326231255861e1490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326231255861e1490&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422520609","title":"Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422520609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422520609?lang=zh_cn&edition=full","pubTime":"2024-03-26 03:12","pubTimestamp":1711393929,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日03时12分,Enanta Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.00%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Altamira Therapeutics Ltd.涨幅较大,Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为3336.68%、449.52%、79.41%,振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Zura Bio Limited,振幅分别为80.35%、78.61%、47.80%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326031209861e0ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326031209861e0ef6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420281285","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报13.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420281285","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420281285?lang=zh_cn&edition=full","pubTime":"2024-03-19 03:05","pubTimestamp":1710788735,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日03时05分,Enanta Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.00%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190305357a4d742d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190305357a4d742d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417408784","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.24%报14.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417408784","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417408784?lang=zh_cn&edition=full","pubTime":"2024-03-06 01:56","pubTimestamp":1709661412,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日01时56分,Enanta Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.24%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.36%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Ocean Biomedical, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为315.94%、206.11%、175.37%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Revelation Biosciences Inc C/Wts 10/01/2027 、Ocean Biomedical, Inc.,振幅分别为101.72%、98.45%、89.22%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306015653861db75e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306015653861db75e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416640142","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416640142","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416640142?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:48","pubTimestamp":1709308082,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时48分,Enanta Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.22%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.26%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Carmell Corp C/Wts 12/07/2028 涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为3442.84%、373.22%、263.02%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.、Biovie Inc.,振幅分别为81.48%、81.19%、76.61%。Enanta Pharmaceuticals, Inc.公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012348027a489965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012348027a489965&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414854077","title":"Enanta Pharmaceuticals Inc盘中异动 急速拉升5.13%报14.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414854077","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414854077?lang=zh_cn&edition=full","pubTime":"2024-02-27 04:18","pubTimestamp":1708978719,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日04时18分,Enanta Pharmaceuticals Inc股票出现波动,股价大幅上涨5.13%。截至发稿,该股报14.15美元/股,成交量11.3239万股,换手率0.54%,振幅4.90%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.73%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022704183987e73352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022704183987e73352&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413247872","title":"Enanta Pharmaceuticals Inc盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413247872","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413247872?lang=zh_cn&edition=full","pubTime":"2024-02-23 02:12","pubTimestamp":1708625559,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日02时12分,Enanta Pharmaceuticals Inc股票出现波动,股价急速下跌5.01%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为2.12%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022302123979138b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022302123979138b3e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411586682","title":"Enanta Pharmaceuticals Inc盘中异动 早盘急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411586682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411586682?lang=zh_cn&edition=full","pubTime":"2024-02-15 00:21","pubTimestamp":1707927706,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日00时21分,Enanta Pharmaceuticals Inc股票出现波动,股价急速上涨5.12%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Cogent Biosciences Inc涨幅较大,Kintara Therapeutics Inc、Azitra Inc、Transcode Therapeutics Inc较为活跃,换手率分别为65.43%、35.32%、33.33%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Fresh2 Group Limited,振幅分别为208.62%、51.31%、41.19%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021500214779116da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021500214779116da1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409674852","title":"Enanta Pharmaceuticals Inc盘中异动 早盘快速下跌8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409674852","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409674852?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:32","pubTimestamp":1707402760,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时32分,Enanta Pharmaceuticals Inc股票出现异动,股价快速下挫8.69%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Tenaya Therapeutics Inc、Foghorn Therapeutics Inc涨幅较大,Tenax Therapeutics Inc、Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp较为活跃,换手率分别为358.43%、24.68%、21.73%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Adverum Biotechnologies Inc、Keros Therapeutics Inc,振幅分别为29.82%、17.08%、12.82%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223240877e09fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223240877e09fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409761527","title":"美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2409761527","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409761527?lang=zh_cn&edition=full","pubTime":"2024-02-08 16:00","pubTimestamp":1707379255,"startTime":"0","endTime":"0","summary":" 路透2月8日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括Idexx Laboratories、Fleetcor Technologies和Huntington Ingalls Industries 。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409285399","title":"Enanta Pharmaceuticals Inc盘中异动 股价大涨5.01%报12.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409285399","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409285399?lang=zh_cn&edition=full","pubTime":"2024-02-07 00:40","pubTimestamp":1707237621,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日00时40分,Enanta Pharmaceuticals Inc股票出现波动,股价快速拉升5.01%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.91%。其相关个股中,Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Revelation Biosciences Inc较为活跃,换手率分别为3194.01%、2443.77%、138.44%,振幅较大的相关个股有Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Karyopharm Therapeutics Inc,振幅分别为143.74%、89.33%、61.48%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020700402187e6e3c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020700402187e6e3c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409630894","title":"Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409630894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409630894?lang=zh_cn&edition=full","pubTime":"2024-02-06 06:02","pubTimestamp":1707170571,"startTime":"0","endTime":"0","summary":" * Enanta Pharmaceuticals Inc 将于2月7日公布截至2023年12月31日的季度财报,预计该公司的季度收入将出现下降。* LSEG 分析师对 Enanta Pharmaceuticals Inc 的平均预期是每股亏损 1.19 美元。* 华尔街对 Enanta Pharmaceuticals Inc 的 12 个月目标价中位数为 22.00 美元,高于其最新收盘价 12.28 美元。2月5日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408960545","title":"Enanta Pharmaceuticals Inc 预计每股亏损 1.19 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2408960545","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408960545?lang=zh_cn&edition=full","pubTime":"2024-02-02 19:04","pubTimestamp":1706871880,"startTime":"0","endTime":"0","summary":" * Enanta Pharmaceuticals Inc 将于2月7日公布截至2023年12月31日的季度财报,预计该公司的季度收入将出现下降。* LSEG 分析师对 Enanta Pharmaceuticals Inc 的平均预期是每股亏损 1.19 美元。* 华尔街对 Enanta Pharmaceuticals Inc 的 12 个月目标价中位数为 22.00 美元,高于其最新收盘价 12.78 美元。2月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408262650","title":"Enanta Pharmaceuticals Inc盘中异动 下午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408262650","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408262650?lang=zh_cn&edition=full","pubTime":"2024-02-02 02:45","pubTimestamp":1706813158,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日02时45分,Enanta Pharmaceuticals Inc股票出现波动,股价快速上涨5.19%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.83%。其相关个股中,Protagenic Therapeutics Inc C/Wts 29/04/2026 、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc涨幅较大,Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃,换手率分别为2712.60%、1197.51%、1032.68%,振幅较大的相关个股有Gri Bio Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc,振幅分别为207.75%、69.32%、64.22%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202024558861d05aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202024558861d05aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405317755","title":"Enanta Pharmaceuticals Inc盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405317755","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405317755?lang=zh_cn&edition=full","pubTime":"2024-01-24 01:17","pubTimestamp":1706030260,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日01时17分,Enanta Pharmaceuticals Inc股票出现异动,股价大幅拉升5.00%。Enanta Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.02%。Enanta Pharmaceuticals Inc公司简介:Enanta Pharmaceuticals Inc是一家美国生物科技公司,致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir,其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124011740861ccdac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124011740861ccdac&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enanta.com","stockEarnings":[{"period":"1week","weight":-0.0771},{"period":"1month","weight":-0.0732},{"period":"3month","weight":0.0513},{"period":"6month","weight":0.5473},{"period":"1year","weight":-0.6282},{"period":"ytd","weight":0.373}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司,利用稳健、化学驱动的方法和药物发现能力,成为小分子药物发现和开发的领导者,重点是病毒感染的治疗。该公司发现了gleCAPrevir,这是通过与艾伯维合作发现和开发的两种蛋白酶抑制剂中的第二种,用于治疗丙型肝炎病毒(HCV)的慢性感染。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.067315},{"month":2,"riseRate":0.545455,"avgChangeRate":0.028424},{"month":3,"riseRate":0.636364,"avgChangeRate":0.006788},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.026041},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.051089},{"month":6,"riseRate":0.454545,"avgChangeRate":0.027971},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.020857},{"month":8,"riseRate":0.545455,"avgChangeRate":0.023055},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.029967},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.023855},{"month":11,"riseRate":0.727273,"avgChangeRate":0.08672},{"month":12,"riseRate":0.727273,"avgChangeRate":0.017471}],"exchange":"NASDAQ","name":"Enanta Pharmaceuticals Inc.","nameEN":"Enanta Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enanta Pharmaceuticals Inc.,ENTA,Enanta Pharmaceuticals Inc.股票,Enanta Pharmaceuticals Inc.股票老虎,Enanta Pharmaceuticals Inc.股票老虎国际,Enanta Pharmaceuticals Inc.行情,Enanta Pharmaceuticals Inc.股票行情,Enanta Pharmaceuticals Inc.股价,Enanta Pharmaceuticals Inc.股市,Enanta Pharmaceuticals Inc.股票价格,Enanta Pharmaceuticals Inc.股票交易,Enanta Pharmaceuticals Inc.股票购买,Enanta Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}